nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—NPY1R—nerve—type 1 diabetes mellitus	0.0328	0.214	CbGeAlD
Duloxetine—HTR2A—arteriole—type 1 diabetes mellitus	0.0278	0.181	CbGeAlD
Duloxetine—Blood potassium increased—Ramipril—type 1 diabetes mellitus	0.023	0.0537	CcSEcCtD
Duloxetine—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.0198	0.129	CbGeAlD
Duloxetine—SLC6A3—nerve—type 1 diabetes mellitus	0.0138	0.0901	CbGeAlD
Duloxetine—Sleep disturbance—Ramipril—type 1 diabetes mellitus	0.0124	0.0289	CcSEcCtD
Duloxetine—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.0119	0.0279	CcSEcCtD
Duloxetine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.0119	0.0777	CbGeAlD
Duloxetine—NPY1R—pancreas—type 1 diabetes mellitus	0.0112	0.0729	CbGeAlD
Duloxetine—SLC6A2—nerve—type 1 diabetes mellitus	0.0111	0.0727	CbGeAlD
Duloxetine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00859	0.056	CbGeAlD
Duloxetine—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00836	0.0196	CcSEcCtD
Duloxetine—Liver injury—Ramipril—type 1 diabetes mellitus	0.00824	0.0193	CcSEcCtD
Duloxetine—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.008	0.0187	CcSEcCtD
Duloxetine—HTR2A—nerve—type 1 diabetes mellitus	0.0067	0.0437	CbGeAlD
Duloxetine—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00627	0.0147	CcSEcCtD
Duloxetine—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00581	0.0136	CcSEcCtD
Duloxetine—Polyuria—Ramipril—type 1 diabetes mellitus	0.00573	0.0134	CcSEcCtD
Duloxetine—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00568	0.0133	CcSEcCtD
Duloxetine—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.0056	0.0131	CcSEcCtD
Duloxetine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00543	0.0127	CcSEcCtD
Duloxetine—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00533	0.0125	CcSEcCtD
Duloxetine—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00531	0.0124	CcSEcCtD
Duloxetine—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00529	0.0124	CcSEcCtD
Duloxetine—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00516	0.0121	CcSEcCtD
Duloxetine—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00516	0.0121	CcSEcCtD
Duloxetine—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00505	0.0118	CcSEcCtD
Duloxetine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00499	0.0117	CcSEcCtD
Duloxetine—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00472	0.011	CcSEcCtD
Duloxetine—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00465	0.0109	CcSEcCtD
Duloxetine—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.0046	0.0108	CcSEcCtD
Duloxetine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.0046	0.0108	CcSEcCtD
Duloxetine—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00455	0.0106	CcSEcCtD
Duloxetine—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00453	0.0106	CcSEcCtD
Duloxetine—Gastritis—Ramipril—type 1 diabetes mellitus	0.00445	0.0104	CcSEcCtD
Duloxetine—Influenza—Ramipril—type 1 diabetes mellitus	0.00435	0.0102	CcSEcCtD
Duloxetine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00435	0.0102	CcSEcCtD
Duloxetine—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00427	0.00998	CcSEcCtD
Duloxetine—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00424	0.00991	CcSEcCtD
Duloxetine—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00417	0.00975	CcSEcCtD
Duloxetine—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00404	0.00946	CcSEcCtD
Duloxetine—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00401	0.00937	CcSEcCtD
Duloxetine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00397	0.00929	CcSEcCtD
Duloxetine—Weight increased—Ramipril—type 1 diabetes mellitus	0.00396	0.00926	CcSEcCtD
Duloxetine—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00385	0.00899	CcSEcCtD
Duloxetine—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00382	0.00894	CcSEcCtD
Duloxetine—Renal failure—Ramipril—type 1 diabetes mellitus	0.00381	0.00892	CcSEcCtD
Duloxetine—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.0038	0.00889	CcSEcCtD
Duloxetine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00378	0.00884	CcSEcCtD
Duloxetine—Jaundice—Ramipril—type 1 diabetes mellitus	0.00378	0.00884	CcSEcCtD
Duloxetine—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00377	0.00882	CcSEcCtD
Duloxetine—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00377	0.00882	CcSEcCtD
Duloxetine—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00367	0.00858	CcSEcCtD
Duloxetine—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00366	0.00856	CcSEcCtD
Duloxetine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00348	0.00814	CcSEcCtD
Duloxetine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00343	0.00802	CcSEcCtD
Duloxetine—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00342	0.008	CcSEcCtD
Duloxetine—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00336	0.00785	CcSEcCtD
Duloxetine—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00329	0.0077	CcSEcCtD
Duloxetine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00325	0.00759	CcSEcCtD
Duloxetine—Flushing—Ramipril—type 1 diabetes mellitus	0.00323	0.00756	CcSEcCtD
Duloxetine—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00315	0.00736	CcSEcCtD
Duloxetine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00314	0.00734	CcSEcCtD
Duloxetine—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00311	0.00728	CcSEcCtD
Duloxetine—Alopecia—Ramipril—type 1 diabetes mellitus	0.00308	0.0072	CcSEcCtD
Duloxetine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00305	0.00713	CcSEcCtD
Duloxetine—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00303	0.00709	CcSEcCtD
Duloxetine—Erythema—Ramipril—type 1 diabetes mellitus	0.00303	0.00709	CcSEcCtD
Duloxetine—Tension—Ramipril—type 1 diabetes mellitus	0.00297	0.00696	CcSEcCtD
Duloxetine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00297	0.00694	CcSEcCtD
Duloxetine—Nervousness—Ramipril—type 1 diabetes mellitus	0.00294	0.00689	CcSEcCtD
Duloxetine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00291	0.00682	CcSEcCtD
Duloxetine—Tremor—Ramipril—type 1 diabetes mellitus	0.00284	0.00664	CcSEcCtD
Duloxetine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00281	0.00658	CcSEcCtD
Duloxetine—Agitation—Ramipril—type 1 diabetes mellitus	0.00279	0.00651	CcSEcCtD
Duloxetine—HTR2A—retina—type 1 diabetes mellitus	0.00277	0.0181	CbGeAlD
Duloxetine—Angioedema—Ramipril—type 1 diabetes mellitus	0.00277	0.00648	CcSEcCtD
Duloxetine—Malaise—Ramipril—type 1 diabetes mellitus	0.00273	0.00639	CcSEcCtD
Duloxetine—Vertigo—Ramipril—type 1 diabetes mellitus	0.00272	0.00637	CcSEcCtD
Duloxetine—Syncope—Ramipril—type 1 diabetes mellitus	0.00272	0.00636	CcSEcCtD
Duloxetine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00271	0.00635	CcSEcCtD
Duloxetine—Palpitations—Ramipril—type 1 diabetes mellitus	0.00268	0.00626	CcSEcCtD
Duloxetine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00266	0.00623	CcSEcCtD
Duloxetine—Cough—Ramipril—type 1 diabetes mellitus	0.00265	0.00619	CcSEcCtD
Duloxetine—Convulsion—Ramipril—type 1 diabetes mellitus	0.00263	0.00614	CcSEcCtD
Duloxetine—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00258	0.00604	CcSEcCtD
Duloxetine—Chest pain—Ramipril—type 1 diabetes mellitus	0.00258	0.00604	CcSEcCtD
Duloxetine—Myalgia—Ramipril—type 1 diabetes mellitus	0.00258	0.00604	CcSEcCtD
Duloxetine—Anxiety—Ramipril—type 1 diabetes mellitus	0.00257	0.00601	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00256	0.00599	CcSEcCtD
Duloxetine—Discomfort—Ramipril—type 1 diabetes mellitus	0.00255	0.00596	CcSEcCtD
Duloxetine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00252	0.0059	CcSEcCtD
Duloxetine—Confusional state—Ramipril—type 1 diabetes mellitus	0.00249	0.00583	CcSEcCtD
Duloxetine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00247	0.00579	CcSEcCtD
Duloxetine—Oedema—Ramipril—type 1 diabetes mellitus	0.00247	0.00579	CcSEcCtD
Duloxetine—Shock—Ramipril—type 1 diabetes mellitus	0.00243	0.00569	CcSEcCtD
Duloxetine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00243	0.00567	CcSEcCtD
Duloxetine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00242	0.00566	CcSEcCtD
Duloxetine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00241	0.00565	CcSEcCtD
Duloxetine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.0024	0.00562	CcSEcCtD
Duloxetine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00239	0.00559	CcSEcCtD
Duloxetine—Anorexia—Ramipril—type 1 diabetes mellitus	0.00236	0.00552	CcSEcCtD
Duloxetine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.00235	0.0153	CbGeAlD
Duloxetine—HTR2A—kidney—type 1 diabetes mellitus	0.00229	0.015	CbGeAlD
Duloxetine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00225	0.00527	CcSEcCtD
Duloxetine—Insomnia—Ramipril—type 1 diabetes mellitus	0.00224	0.00523	CcSEcCtD
Duloxetine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00222	0.0052	CcSEcCtD
Duloxetine—Somnolence—Ramipril—type 1 diabetes mellitus	0.0022	0.00514	CcSEcCtD
Duloxetine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00218	0.00509	CcSEcCtD
Duloxetine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00215	0.00503	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00214	0.005	CcSEcCtD
Duloxetine—Fatigue—Ramipril—type 1 diabetes mellitus	0.00213	0.00499	CcSEcCtD
Duloxetine—Constipation—Ramipril—type 1 diabetes mellitus	0.00212	0.00495	CcSEcCtD
Duloxetine—CYP2D6—kidney—type 1 diabetes mellitus	0.00209	0.0136	CbGeAlD
Duloxetine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00204	0.00477	CcSEcCtD
Duloxetine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00202	0.00473	CcSEcCtD
Duloxetine—Urticaria—Ramipril—type 1 diabetes mellitus	0.00197	0.0046	CcSEcCtD
Duloxetine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00196	0.00457	CcSEcCtD
Duloxetine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00196	0.00457	CcSEcCtD
Duloxetine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00182	0.00426	CcSEcCtD
Duloxetine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00178	0.00415	CcSEcCtD
Duloxetine—Pruritus—Ramipril—type 1 diabetes mellitus	0.00175	0.00409	CcSEcCtD
Duloxetine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00169	0.00396	CcSEcCtD
Duloxetine—Dizziness—Ramipril—type 1 diabetes mellitus	0.00164	0.00383	CcSEcCtD
Duloxetine—Vomiting—Ramipril—type 1 diabetes mellitus	0.00157	0.00368	CcSEcCtD
Duloxetine—Rash—Ramipril—type 1 diabetes mellitus	0.00156	0.00365	CcSEcCtD
Duloxetine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00156	0.00364	CcSEcCtD
Duloxetine—Headache—Ramipril—type 1 diabetes mellitus	0.00155	0.00362	CcSEcCtD
Duloxetine—Nausea—Ramipril—type 1 diabetes mellitus	0.00147	0.00344	CcSEcCtD
Duloxetine—NPY1R—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000305	0.000729	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000304	0.000726	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.0003	0.000716	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000298	0.000711	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000295	0.000703	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000293	0.000699	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000287	0.000684	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.000287	0.000684	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00028	0.000668	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00028	0.000667	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000278	0.000663	CbGpPWpGaD
Duloxetine—SLC6A3—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.000278	0.000663	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000277	0.000662	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000277	0.000661	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000276	0.000659	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000273	0.000652	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000273	0.000652	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000271	0.000646	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000269	0.000641	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000268	0.00064	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000267	0.000638	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000267	0.000638	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000265	0.000633	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000264	0.00063	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000261	0.000624	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000261	0.000622	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.00026	0.000621	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.00026	0.000621	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00026	0.00062	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000259	0.000617	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000256	0.000611	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000256	0.00061	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000254	0.000606	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000252	0.000601	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000252	0.0006	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000251	0.000598	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.000249	0.000594	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000249	0.000593	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000247	0.00059	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000241	0.000574	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000238	0.000568	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000235	0.000561	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000233	0.000556	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000233	0.000555	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000232	0.000554	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000232	0.000554	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000231	0.000551	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00023	0.00055	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000226	0.000539	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000224	0.000535	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000218	0.000521	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000217	0.000518	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000216	0.000515	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000216	0.000515	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000215	0.000512	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000215	0.000512	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000214	0.00051	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000213	0.000509	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000211	0.000504	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00021	0.000501	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000209	0.000499	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000204	0.000487	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000203	0.000485	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000202	0.000482	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000202	0.000482	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—INS—type 1 diabetes mellitus	0.000202	0.000482	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000202	0.000481	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000196	0.000468	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000195	0.000466	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000195	0.000465	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000194	0.000464	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000185	0.000442	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000185	0.00044	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000183	0.000438	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000182	0.000435	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000182	0.000434	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000181	0.000432	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.00018	0.00043	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000179	0.000426	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000177	0.000423	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000177	0.000423	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000177	0.000421	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000176	0.00042	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000175	0.000418	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00017	0.000407	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00017	0.000406	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00017	0.000405	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000169	0.000404	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000169	0.000404	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000165	0.000394	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000162	0.000387	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000161	0.000384	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00016	0.000382	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.00016	0.000382	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00016	0.000381	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000159	0.00038	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000159	0.00038	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000158	0.000378	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000158	0.000377	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000158	0.000377	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000158	0.000377	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000157	0.000376	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000154	0.000369	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000154	0.000368	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000152	0.000363	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000151	0.00036	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.00015	0.000359	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL2—type 1 diabetes mellitus	0.00015	0.000358	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000149	0.000356	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SST—type 1 diabetes mellitus	0.000149	0.000355	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000149	0.000355	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000148	0.000353	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000148	0.000353	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000147	0.000352	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000146	0.000349	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000144	0.000342	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000142	0.000339	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000141	0.000337	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.00014	0.000335	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000139	0.000331	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000138	0.00033	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000137	0.000327	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000137	0.000327	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000134	0.00032	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000134	0.000319	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000133	0.000318	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000133	0.000316	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000132	0.000314	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00013	0.000309	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000129	0.000308	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	0.000128	0.000305	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000128	0.000304	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000126	0.000301	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000126	0.0003	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000125	0.000298	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000125	0.000298	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000124	0.000296	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000124	0.000295	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000123	0.000294	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000122	0.000291	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	0.00012	0.000287	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000119	0.000285	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000118	0.000281	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000116	0.000276	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000115	0.000274	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000114	0.000273	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000113	0.000269	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000113	0.000269	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000112	0.000268	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SST—type 1 diabetes mellitus	0.00011	0.000261	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000109	0.00026	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000109	0.00026	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000108	0.000259	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000108	0.000259	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000108	0.000258	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000104	0.000249	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000104	0.000248	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000103	0.000246	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000103	0.000245	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000102	0.000244	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—GCG—type 1 diabetes mellitus	9.76e-05	0.000233	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.75e-05	0.000233	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	9.73e-05	0.000232	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.58e-05	0.000229	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SST—type 1 diabetes mellitus	9.51e-05	0.000227	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.47e-05	0.000226	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.45e-05	0.000225	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.4e-05	0.000224	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.37e-05	0.000224	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.13e-05	0.000218	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.1e-05	0.000217	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL6—type 1 diabetes mellitus	8.82e-05	0.000211	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—GCG—type 1 diabetes mellitus	8.48e-05	0.000202	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.3e-05	0.000198	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.26e-05	0.000197	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	8.24e-05	0.000197	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	8.21e-05	0.000196	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.16e-05	0.000195	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CD86—type 1 diabetes mellitus	7.96e-05	0.00019	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.93e-05	0.000189	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.9e-05	0.000189	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CD80—type 1 diabetes mellitus	7.88e-05	0.000188	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	7.73e-05	0.000184	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	7.68e-05	0.000183	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.6e-05	0.000181	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.55e-05	0.00018	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	7.54e-05	0.00018	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—INS—type 1 diabetes mellitus	7.45e-05	0.000178	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.21e-05	0.000172	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.2e-05	0.000172	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.18e-05	0.000171	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.18e-05	0.000171	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.17e-05	0.000171	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.06e-05	0.000168	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	6.96e-05	0.000166	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.96e-05	0.000166	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CD86—type 1 diabetes mellitus	6.91e-05	0.000165	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.9e-05	0.000165	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.66e-05	0.000159	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.6e-05	0.000158	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.56e-05	0.000156	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	6.55e-05	0.000156	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.53e-05	0.000156	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	6.51e-05	0.000155	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	6.39e-05	0.000152	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.23e-05	0.000149	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.13e-05	0.000146	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.04e-05	0.000144	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	6.01e-05	0.000143	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.99e-05	0.000143	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.89e-05	0.000141	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	5.81e-05	0.000139	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.55e-05	0.000132	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	5.54e-05	0.000132	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.51e-05	0.000131	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	5.49e-05	0.000131	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.31e-05	0.000127	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.28e-05	0.000126	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	5.09e-05	0.000121	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	5.09e-05	0.000121	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.04e-05	0.00012	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.9e-05	0.000117	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.81e-05	0.000115	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	4.76e-05	0.000114	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.66e-05	0.000111	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.61e-05	0.00011	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.58e-05	0.000109	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	4.31e-05	0.000103	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.26e-05	0.000102	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.24e-05	0.000101	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.18e-05	9.97e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.08e-05	9.75e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	4.08e-05	9.73e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.06e-05	9.68e-05	CbGpPWpGaD
Duloxetine—Propranolol—ADRB1—type 1 diabetes mellitus	4.02e-05	0.603	CrCbGaD
Duloxetine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.55e-05	8.46e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.54e-05	8.45e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.52e-05	8.41e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.43e-05	8.19e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.38e-05	8.06e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	3.25e-05	7.77e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.12e-05	7.44e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3.1e-05	7.39e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.98e-05	7.11e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.96e-05	7.07e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	2.86e-05	6.83e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.71e-05	6.46e-05	CbGpPWpGaD
Duloxetine—Fluoxetine—ALB—type 1 diabetes mellitus	2.64e-05	0.397	CrCbGaD
Duloxetine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.62e-05	6.26e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.51e-05	5.99e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.4e-05	5.72e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.08e-05	4.97e-05	CbGpPWpGaD
